APA (7th ed.) Citation

MD, K., PJ, H., YY, C., P, A., CC, D., MR, V., . . . MA, P. (2024). Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): A two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment. Nature communications, 15(1), 3258. https://doi.org/10.1038/s41467-024-47057-2

Chicago Style (17th ed.) Citation

MD, Keller, et al. "Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES): A Two-arm, Open Label Phase II Interventional Trial of Pediatric Patients with Risk Factor Assessment." Nature Communications 15, no. 1 (2024): 3258. https://doi.org/10.1038/s41467-024-47057-2.

MLA (9th ed.) Citation

MD, Keller, et al. "Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES): A Two-arm, Open Label Phase II Interventional Trial of Pediatric Patients with Risk Factor Assessment." Nature Communications, vol. 15, no. 1, 2024, p. 3258, https://doi.org/10.1038/s41467-024-47057-2.